TCTMD

TCT 328: Determining Beneficiaries of 2-Stent Strategy by BIFURCAT Two-Stent Score in a Large-scale Coronary Bifurcation Registry

TCT 733: Cardiovascular Outcomes After True Bifurcation PCI: Insights From a Large Real-World Registry. Receive the the latest news, research, and presentations from major meetings right to your inbox ...
TCTMD

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

PARIS, France—A stepwise, provisional approach to PCI in bifurcation lesions continues to offer similar outcomes compared with a strategy in which two stents are the plan from the outset. Here at ...
Medical Xpress

Dual-antiplatelet therapy should remain standard strategy after stent implantation, research finds

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...
Medscape

In Separate Trials, Sirolimus-Eluting Balloons Challenge Stents for Common PCI Indications

SAN FRANCISCO — A sirolimus-eluting balloon was found to be noninferior to conventional stenting in separate trials of patients undergoing percutaneous coronary interventions (PCIs), suggesting these ...
The New England Journal of Medicine

Optical Coherence Tomography–Guided versus Angiography-Guided PCI

Data regarding clinical outcomes after optical coherence tomography (OCT)–guided percutaneous coronary intervention (PCI) as compared with angiography-guided PCI are limited. In this prospective, ...
EurekAlert!

Dual-antiplatelet therapy should remain standard strategy after stent implantation

Amsterdam, Netherlands – 26 Aug 2023: Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major ...